FIGO regularly issues statements and joint statements.

FIGO’s Accelerating Measurable Progress and Leveraging Investments for Postpartum Haemorrhage Impact (AMPLI-PPHI) project aims to dramatically reduce maternal mortality and morbidity from PPH.

We have recently witnessed some policy changes that have led to the expanded registration of mifepristone, a crucial ...

Post-partum haemorrhage (PPH) is the leading cause of maternal mortality globally, accounting for over 20% of maternal deaths worldwide. Although PPH is largely preventable, it continues to ...

Each month FIGO shares news from throughout our 139 National Member Societies, notable highlights from our programme teams, and global advocacy activity.

This World Prematurity Day, FIGO calls on healthcare providers, policymakers, and communities to champion better care for ...

The International Journal of Gynecology & Obstetrics (IJGO) has published a special article by the FIGO Committee on Ethical ...

The International Journal of Gynecology & Obstetrics (IJGO) has published a special article by the FIGO Committee on Ethical Aspects of Human Reproduction and Women… In August 2024, the FIGO Fistula ...

The US election put reproductive rights at the heart of a political ballot. But the impact of the result will be felt far beyond America. Millions of women and girls around the world who didn’t get a ...

Over the summer months, FIGO conducted in-depth interviews with 13 members of the LDI Voices network to gather insights into their experiences and perspectives. Representing all six programme ...